Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that a woman has both Frontal Fibrosing Alopecia and Lichen Simplex Chronicus, a previously unreported combination of conditions.

A woman with CCCA has hair loss due to factors like straighteners and tight hairstyles, and treatments include steroids and avoiding certain hair products.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Cicatricial alopecia causes permanent hair loss and is treated to relieve symptoms and stop progression.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Oral isotretinoína effectively stabilizes frontal fibrosing alopecia.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Detailed history and physical examination are crucial for diagnosing hair loss.

The document covers various dermatological treatments and conditions.

Some women with common hair loss may develop permanent hair loss.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Lichen planopilaris mostly affects women with fair skin and can look different on each person, needing early treatment to prevent hair loss.

Trichoscopy is a useful tool for diagnosing hair and scalp diseases without needing skin biopsies.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

Two trichoscopic patterns found in hair loss: diffuse fibrotic and androgenetic alopecia, affecting treatment choice and regrowth chances.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Lymecycline may help with Frontal Fibrosing Alopecia but needs more research.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Lichen Planopilaris in teens is rare, often misdiagnosed, and responds well to steroids.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

Keloids significantly reduce quality of life, and treating symptoms should be prioritized.